Skip to main contentSkip to navigationSkip to search
ENZY  
SEK  %
Logotype
ENZY  
SEK  %
Logotype

Media

Press releases

2021

maj 21, 2021 - Non-regulatory press release
Patent for ColdZyme approved in Japan
maj 12, 2021 - Regulatory press release
Prospectus for Enzymatica’s rights issue is published
maj 5, 2021 - Regulatory press release
Bulletin from Annual General Meeting of Enzymatica AB (publ) on 5 May 2021
april 29, 2021 - Regulatory press release
Lower sales due to the pandemic but new rights issue secures continued international expansion
mars 31, 2021 - Regulatory press release
Enzymatica Publication of the Annual Report 2020
mars 31, 2021 - Regulatory press release
Notice of Annual General Meeting 2021 in Enzymatica AB (publ)
mars 29, 2021 - Regulatory press release
Enzymatica’s Board of Directors decides on a new rights issue of SEK 59.1 million
mars 22, 2021 - Regulatory press release
Enzymatica’s sales and result affected by the pandemic
februari 18, 2021 - Regulatory press release
Positive operating result and almost doubled sales for the fourth quarter
februari 11, 2021 - Regulatory press release
Enzymatica comments on article in Dagens Medicin
januari 15, 2021 - Non-regulatory press release
New strategic recruitments and organizational changes at Enzymatica

2020

december 9, 2020 - Non-regulatory press release
STADA agreement extended for the Nordic Region
november 12, 2020 - Regulatory press release
Enzymatica enters agreement with MS Pharma for MENA
november 3, 2020 - Regulatory press release
Continued strong sales increase and positive cash flow in third quarter
oktober 21, 2020 - Regulatory press release
Enzymatica enters agreement with Sanofi for covering France and Italy on common cold spray Coldzyme®
oktober 13, 2020 - Regulatory press release
Enzymatica and STADA extend agreement on ViruProtect to Russia, Poland, Ukraine and CIS countries
oktober 7, 2020 - Non-regulatory press release
ColdZyme launched in Israel
september 28, 2020 - Non-regulatory press release
The Journal of Medical Virology has peer reviewed, approved and published the results of Enzymatica’s in vitro study on SARS-CoV-2
september 23, 2020 - Non-regulatory press release
New patents approved for ColdZyme in Japan and Russia
september 17, 2020 - Non-regulatory press release
New version – corrected 17 September, 2020 The results of Enzymatica's placebo-controlled, randomized study
Load more